| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/24/1998 | CA2215647A1 Naphthyl compounds, compositions, and methods |
| 04/23/1998 | WO1998016655A1 Human plasma hyaluronidase |
| 04/23/1998 | WO1998016643A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 04/23/1998 | WO1998016637A1 Fanconi gene 1 |
| 04/23/1998 | WO1998016551A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 04/23/1998 | WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016512A1 New derivates from piperidine-keto acid, their preparation and use |
| 04/23/1998 | WO1998016506A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016254A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/23/1998 | WO1998016249A1 Methods and compositions for immunomodulation |
| 04/23/1998 | WO1998016246A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | WO1998016238A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 04/23/1998 | WO1998016235A1 Peripheral blood stem cell-increasing agents containing glycosides |
| 04/23/1998 | WO1998016227A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 04/23/1998 | WO1998016204A1 Process for the manufacture of a pulverous preparation |
| 04/23/1998 | WO1998016202A2 Fusogenic liposome composition and method |
| 04/23/1998 | WO1998016201A1 Therapeutic liposome composition and method |
| 04/23/1998 | WO1998016200A1 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 04/23/1998 | WO1998016186A2 Monocyclic l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998016184A2 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998011101A3 Condensed n-aclyindoles as antitumor agents |
| 04/23/1998 | WO1998009992A3 Htm4, methods of treatment and assays, agonists and antagonists |
| 04/23/1998 | WO1998009170A3 Methods and compositions for the detection of cervical cancer |
| 04/23/1998 | WO1998008546A3 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/23/1998 | WO1998004702A3 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 04/23/1998 | CA2268917A1 New derivates from piperidine-keto acid, their preparation and use |
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268895A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268841A1 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 04/23/1998 | CA2268340A1 Methods and compositions for immunomodulation |
| 04/23/1998 | CA2268007A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 04/23/1998 | CA2267977A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | CA2267279A1 Monocyclic l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2267110A1 Fanconi gene i |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/22/1998 | EP0837133A2 DNA strand resolution proteins of the resolvase family |
| 04/22/1998 | EP0837129A1 Epimorphin antagonist and process for producing the same |
| 04/22/1998 | EP0837127A2 Hereditary multiple exostose gene, Ext2 |
| 04/22/1998 | EP0837073A1 Human mad proteins and uses thereof |
| 04/22/1998 | EP0837063A1 4-Aminoquinazoline derivatives |
| 04/22/1998 | EP0836610A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 04/22/1998 | EP0836605A1 Pyrrolopyrimidines and processes for the preparation thereof |
| 04/22/1998 | EP0836480A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof |
| 04/22/1998 | EP0836476A1 A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders |
| 04/22/1998 | EP0836383A1 Combinations of inhibitors of farnesyl-protein transferase |
| 04/22/1998 | EP0836380A1 Fgf9 as a specific ligand for fgfr3 |
| 04/22/1998 | EP0764027A4 Method for protection against genotoxic mutagenesis |
| 04/22/1998 | EP0708755B1 Novel vitamin d analogues |
| 04/22/1998 | EP0536275B1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/22/1998 | CN1179777A Novel taxoids ,preparation thereof, and pharmaceutical compositions containing same |
| 04/22/1998 | CN1179776A Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 04/22/1998 | CN1179775A Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 04/22/1998 | CN1179418A Novel cyloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/21/1998 | US5741892 Pentapeptides as antitumor agents |
| 04/21/1998 | US5741819 Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741810 Prostaglandins for ocular hypotension for treatment of glaucoma |
| 04/21/1998 | US5741809 Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders |
| 04/21/1998 | US5741679 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/16/1998 | WO1998015643A1 Fragments of plasminogen effective in inhibiting tumor metastasis and growth and process for preparing the same |
| 04/16/1998 | WO1998015632A1 A human protein tyrosine kinase |
| 04/16/1998 | WO1998015631A1 Attenuated microorganism strains expressing hpv proteins |
| 04/16/1998 | WO1998015624A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | WO1998015616A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | WO1998015615A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | WO1998015580A1 Monoclonal antibodies against a human act and serine protease complex |
| 04/16/1998 | WO1998015574A1 Methods and compositions for generating angiostatin |
| 04/16/1998 | WO1998015571A1 Modified cytostatic agents |
| 04/16/1998 | WO1998015563A1 Tetraphosphonate bicyclic trisanhydrides |
| 04/16/1998 | WO1998015556A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS |
| 04/16/1998 | WO1998015554A1 Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
| 04/16/1998 | WO1998015534A1 Novel pyrimidine derivatives and antitumor agents containing the same as the active ingredient |
| 04/16/1998 | WO1998015294A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | WO1998015287A1 Vaccines |
| 04/16/1998 | WO1998015282A1 Immunogenic tlp composition |
| 04/16/1998 | WO1998009970A3 Alkylated rapamycin derivatives |
| 04/16/1998 | WO1998007876A3 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 04/16/1998 | DE19642591A1 Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung New piperidine-ketocarboxylic acid derivatives, their preparation and application |
| 04/16/1998 | DE19641560A1 Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease Monoclonal antibodies against a complex of human ACT and a serine protease |
| 04/16/1998 | DE19640970A1 Modifizierte Cytostatika Modified cytostatics |
| 04/16/1998 | CA2269090A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | CA2268417A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | CA2268284A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | CA2268283A1 Attenuated microorganism strains expressing hpv proteins |
| 04/16/1998 | CA2268022A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | CA2267905A1 Immunogenic tlp composition |
| 04/16/1998 | CA2267660A1 Monoclonal antibodies against a complex composed of human act and a serine protease |
| 04/16/1998 | CA2267191A1 Vaccines |
| 04/16/1998 | CA2266424A1 A human protein tyrosine kinase |
| 04/16/1998 | CA2265550A1 Methods and compositions for generating angiostatin |
| 04/15/1998 | EP0835937A2 Human MYT-1 kinase clone |
| 04/15/1998 | EP0835878A1 Benzo (b) thiophene compounds, intermediates, formulations, and methods |
| 04/15/1998 | EP0835872A1 Benzo [b] thiophene compounds, intermediates, formulations, and methods |
| 04/15/1998 | EP0835871A1 Benzo [b] thiophene compounds, intermediates, formulations, and methods |
| 04/15/1998 | EP0835868A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/15/1998 | EP0835319A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
| 04/15/1998 | EP0835312A2 Recombinant mistletoe lectin |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |